Viewing Study NCT02217605


Ignite Creation Date: 2025-12-25 @ 3:27 AM
Ignite Modification Date: 2026-02-21 @ 9:46 AM
Study NCT ID: NCT02217605
Status: COMPLETED
Last Update Posted: 2014-08-15
First Post: 2014-08-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: 31P Magnetic Resonance Spectroscopy Fructose Study
Sponsor: Stephen Bawden
Organization:

Study Overview

Official Title: Investigating the Effects of an Oral Fructose Challenge on Hepatic ATP Reserves in Healthy Volunteers
Status: COMPLETED
Status Verified Date: 2014-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: 31PMRS_FRU
Brief Summary: The purpose of this study is to determine the effects of an oral fructose challenge on liver adenosine triphosphate (ATP) reserves using 31P magnetic resonance spectroscopy (MRS) as a potential measure measure of liver health.
Detailed Description: This study uses 31P spectra acquired from the liver in healthy subjects following a fructose drink to monitor ATP levels. This is also related to baseline BMI, liver glycogen and liver lipid levels

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: